Frantz Victor
15Patents
7h-index
55Co-inventors
69Inventor score
Filing activity: Apr 14, 1989 → Jul 3, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5891874A | Anti-viral compound | Chemistry; Metallurgy | 66 | Expired |
| US7820671B2 | Peptidomimetic protease inhibitors | Emerging Cross-Sectional Technologies | 21 | Expired |
| US8252923B2 | Peptidomimetic protease inhibitors | Emerging Cross-Sectional Technologies | 14 | Active |
| US5545653A | Anti-viral compounds | Human Necessities | 12 | Expired |
| US7423050B2 | Pyridinoylpiperidines as 5-HT1F agonists | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5821242A | Anti-viral compounds | Human Necessities | 9 | Expired |
| US7291632B2 | Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists | Chemistry; Metallurgy | 8 | Expired |
| US8748459B2 | Pyridinoylpiperidines as 5-HT1F agonists | Emerging Cross-Sectional Technologies | 5 | Active |
| US5693661A | Anti-viral compounds | Human Necessities | 3 | Expired |
| US8529882B2 | Peptidomimetic protease inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US8022062B2 | 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists | Chemistry; Metallurgy | 2 | Active |
| US7312236B2 | Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-HT1F agonists | Chemistry; Metallurgy | 1 | Expired |
| US7981882B2 | 6-N-linked heterocycle-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists | Chemistry; Metallurgy | 0 | Active |
| US8580780B2 | 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist | Chemistry; Metallurgy | 0 | Active |
| US5093324A | Thiadiazole antiviral agents | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.